Dr. Amirhassan Bahreman, MD

Dr. Bahreman practices at Neurological and Pain Institute Inc in La Mesa, California.

Dr. Bahreman's NPI, 1164426953, was assigned on June 9, 2005. Dr. Bahreman graduated from Mashhad University of Medical Sciences in 1993. Dr. Bahreman's Indiana license number on file is 01059340A.

Dr. Bahreman's primary practice is Neurological and Pain Institute Inc, at 8130 La Mesa Blvd, La Mesa, CA 91942 in San Diego County. The practice phone is (619) 460-5850.

Dr. Bahreman's primary practice is Neurological and Pain Institute Inc in La Mesa, California. Dr. Bahreman is also affiliated with Sharp Grossmont Hospital. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Bahreman to 2 more hospitals, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bahreman practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Bahreman's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Bahreman is board certified in brain injury medicine by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Bahreman's licenses on file in 3 states: Indiana, California and Illinois.

Dmand AI lists acute mini-stroke (TIA), carpal tunnel syndrome, cerebrovascular disease, epilepsy, essential tremor, fibromyalgia and chronic pain, head injury and hereditary polyneuropathy among the conditions Dr. Bahreman treats.

CMS data shows 1,430 Medicare services from Dr. Bahreman across 8 procedure codes in 2024, for 412 Medicare patients. Medicare paid $211,178 for them. Every service was in an office.

CMS counts 412 Medicare patients who saw Dr. Bahreman in 2024. The largest group is 65 to 74, with 169 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bahreman's median patient age at 66, with 62% women.

In 2024, Dr. Bahreman wrote 1,626 Medicare Part D claims for 327 patients. 91% of them were for generic drugs. CMS names the drug for 1,361 of them, across 28 drugs with 11 or more claims each, at $165,861 in total drug cost. In 2023, CMS named 1,303 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Bahreman for performance year 2024, reported individually. Dr. Bahreman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1,033 general payments to Dr. Bahreman from 71 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. UCB, Inc. paid the most, $2,863.

Dr. Bahreman graduated from Mashhad University of Medical Sciences in 1993.

Dr. Bahreman is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.